Adherence to Guideline Recommendations for Management of Clinical T1 Renal Cancers in the Netherlands: a Population-based Study

Overview

Journal World J Urol

Specialty Urology

Date 2016 May 15

PMID 27178711

Citations 9

Authors

Katja K H Aben

Susanne Osanto

Christina A Hulsbergen-van de Kaa

Patricia M Soetekouw

Daphne Stemkens

Axel Bex

Affiliations

Soon will be listed here.

Abstract

Purpose: For decades, small renal cancers are treated by radical nephrectomy (RN). Current guidelines recommend partial nephrectomy (PN) to preserve renal function and minimize cardiovascular comorbidity. As adherence to guidelines is largely unknown and international comparison to evaluate quality of health care is lacking, an pre-specified guideline evaluation of quality indicators concerning management of cT1 renal cancers was performed.

Methods: We performed a cohort study including patients with cT1 renal cancer between 2010 and 2014, identified through the Netherlands Cancer Registry. Time trends and variation in treatment were described. Factors associated with PN in cT1a and laparoscopic RN in cT1b were evaluated with logistic regression analyses.

Results: An increase in nephron-sparing treatment strategies (NSS) of cT1a patients (N total = 2436) was observed; in 2014, 67 % underwent NSS (62 % PN and 5 % thermal ablation). Age, a non-central tumor localization and being treated in a high-volume hospital were associated with PN. Although NSS were applied more frequently over time, the majority (70 %) of cT1b patients (N total = 2205) underwent RN in 2014, mainly performed laparoscopically. Increasing tumor size, tumor localization in the right kidney and being treated in a university hospital were associated with a lower probability of a laparoscopic RN versus open. Treatment in a high-volume hospital was associated with a higher probability of laparoscopic RN.

Conclusions: Dutch patients with cT1 renal cancer are predominantly treated according to current guidelines. Data of this pre-specified quality indicator analysis of a urological national guideline may serve as a model for international comparison of treatment of cT1 renal cancers.

Citing Articles

Surgical Management of Renal Cell Carcinoma: Comparisons of open and laparoscopic approaches.

Junejo N, AbuDraz N, Aquil S, Mathew J, Al Badaai G, Al-Marhoon M Sultan Qaboos Univ Med J. 2024; 24(3):383-387.

PMID: 39234317 PMC: 11370946. DOI: 10.18295/squmj.6.2024.033.

The impact of the COVID-19 pandemic on renal cancer care.

Yildirim H, Bins A, van den Hurk C, Jeroen A van Moorselaar R, van Oijen M, Bex A World J Urol. 2024; 42(1):231.

PMID: 38613582 PMC: 11016011. DOI: 10.1007/s00345-024-04925-2.

Trends in the surgical management of kidney cancer by tumor stage, treatment modality, facility type, and location.

Okhawere K, Pandav K, Grauer R, Wilson M, Saini I, Korn T J Robot Surg. 2023; 17(5):2451-2460.

PMID: 37470910 DOI: 10.1007/s11701-023-01664-1.

Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study.

Yildirim H, Schuurman M, Widdershoven C, Lagerveld B, van den Brink L, Ruiter A BJUI Compass. 2023; 4(4):455-463.

PMID: 37334025 PMC: 10268570. DOI: 10.1002/bco2.229.

Trends in the surgical management of renal cell carcinoma in a contemporary tertiary care setting.

Junejo N, Alkhateeb S, Alrumayyan M, Alkhatib K, Alzahrani H, Alotaibi M Urol Ann. 2021; 13(2):111-118.

PMID: 34194135 PMC: 8210727. DOI: 10.4103/UA.UA_151_20.

References

Volpe A, Amparore D, Mottrie A . Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol. 2013; 23(5):403-10. DOI: 10.1097/MOU.0b013e328363a5c0. View

Huang W, Elkin E, Levey A, Jang T, Russo P . Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?. J Urol. 2008; 181(1):55-61. PMC: 2748741. DOI: 10.1016/j.juro.2008.09.017. View

Dulabon L, Lowrance W, Russo P, Huang W . Trends in renal tumor surgery delivery within the United States. Cancer. 2010; 116(10):2316-21. PMC: 4235157. DOI: 10.1002/cncr.24965. View

Bjurlin M, Walter D, Taksler G, Huang W, Wysock J, Sivarajan G . National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology. 2013; 82(6):1283-9. PMC: 3852430. DOI: 10.1016/j.urology.2013.07.068. View

Weight C, Larson B, Gao T, Campbell S, Lane B, Kaouk J . Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology. 2010; 76(3):631-7. DOI: 10.1016/j.urology.2009.11.087. View

Woldrich J, Palazzi K, Stroup S, Sur R, Parsons J, Chang D . Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008. BJU Int. 2013; 111(8):1261-8. DOI: 10.1111/j.1464-410X.2012.11497.x. View

van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A . A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2010; 59(4):543-52. DOI: 10.1016/j.eururo.2010.12.013. View

Miller D, Schonlau M, Litwin M, Lai J, Saigal C . Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2007; 112(3):511-20. DOI: 10.1002/cncr.23218. View

Delahunt B, Egevad L, Montironi R, Srigley J . International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol. 2013; 37(10):1463-8. DOI: 10.1097/PAS.0b013e318299f14a. View

10.

Patel S, Penson D, Pabla B, Clark P, Cookson M, Chang S . National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol. 2012; 187(3):816-21. DOI: 10.1016/j.juro.2011.10.173. View

11.

Campbell S, Novick A, Belldegrun A, Blute M, Chow G, Derweesh I . Guideline for management of the clinical T1 renal mass. J Urol. 2009; 182(4):1271-9. DOI: 10.1016/j.juro.2009.07.004. View

12.

MacLennan S, Imamura M, Lapitan M, Omar M, Lam T, Hilvano-Cabungcal A . Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012; 61(5):972-93. DOI: 10.1016/j.eururo.2012.02.039. View

13.

Schouten L, Straatman H, Kiemeney L, Gimbrere C, Verbeek A . The capture-recapture method for estimation of cancer registry completeness: a useful tool?. Int J Epidemiol. 1994; 23(6):1111-6. DOI: 10.1093/ije/23.6.1111. View

14.

Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View

15.

Ljungberg B, Cowan N, Hanbury D, Hora M, Kuczyk M, Merseburger A . EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010; 58(3):398-406. DOI: 10.1016/j.eururo.2010.06.032. View

16.

El-Ghazaly T, Mason R, Rendon R . Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review. Can Urol Assoc J. 2014; 8(1-2):61-6. PMC: 3929483. DOI: 10.5489/cuaj.1682. View

17.

Weight C, Larson B, Fergany A, Gao T, Lane B, Campbell S . Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010; 183(4):1317-23. DOI: 10.1016/j.juro.2009.12.030. View

18.

Lane B, Chen H, Morrow M, Anema J, Kahnoski R . Increasing use of kidney sparing approaches for localized renal tumors in a community based health system: impact on renal functional outcomes. J Urol. 2011; 186(4):1229-35. DOI: 10.1016/j.juro.2011.05.081. View

19.

Ljungberg B, Gudmundsson E, Christensen S, Lundstam S . Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study. Scand J Urol. 2014; 48(5):445-52. DOI: 10.3109/21681805.2014.898686. View

20.

Jewett M, Mattar K, Basiuk J, Morash C, Pautler S, Siemens D . Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011; 60(1):39-44. DOI: 10.1016/j.eururo.2011.03.030. View